Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendationEric Legius, C. Oliver Hanemann, Yemima Berman et al.|Genetics in Medicine|2021Cited by 766
Peripheral myelin protein–22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot–Marie–Tooth 1ANorisada Matsunami, Phillip F. Chance, Brooke Smith et al.|Nature Genetics|1992Cited by 294
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2Sylwia Ammoun, C. Oliver Hanemann|Neuro-Oncology|2011Cited by 54
GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningiomaCaterina Negroni, C. Oliver Hanemann|EBioMedicine|2020Cited by 41
Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic TargetKayleigh Bassiri, C. Oliver Hanemann|EBioMedicine|2017Cited by 30